Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Accent Microcell Ltd.
₹350
₹350.00
₹356.95
₹170.26
₹378.00
Markets Today
Historical Performance
Indicator | Sep 2023 | Jun 2023 |
|---|---|---|
| Total Revenue | 50.49 | 58.81 |
| Operating Expense | 39.70 | 50.09 |
| Operating Profit | 10.80 | 8.71 |
| Depreciation | 1.11 | 1.02 |
| Interest | 0.31 | 0.53 |
| Tax | 1.96 | 1.22 |
| Net Profit | 7.05 | 7.06 |
₹350.00
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoter | 55.1 | 55.1 | 55.1 | 55.4 | 55.4 |
| FII | 0 | 0 | 0 | 0 | 0.3 |
| DII | 1.7 | 2.2 | 2.9 | 3.3 | 3.6 |
| Public | 43.2 | 42.7 | 42 | 41.3 | 40.7 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 81 K | 1.14 L | 71.05% |
| Week | 24.8 K | 34.7 K | 71.47% |
| 1 Month | 16.46 K | 23.48 K | 70.09% |
| 6 Month | 24.05 K | 30.55 K | 78.71% |
Benjamin Graham Value Screen
Price crossing above SMA20 today, and greater than SMA5
Strong Momentum: Price above short, medium and long term moving averages
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Stocks gaining versus previous close, open price and RSI
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Highest Recovery from 52 Week Low
RSI indicating price strength
MACD crossed above zero line previous end of day
Biggest Price Gainers from Open
Volume Shockers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 16 Sep, 2025 | 1 | FINAL | 16 Sep, 2025 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹7.53 | ₹98 | ₹100.83 | ₹107.50 | ₹22.50 | ₹207.25 |
| % Change | 0.13% | -1.01% | -3.82% | -0.64% | 0.00% | -0.36% |
| Revenue TTM (₹ Cr) | ₹104.12 | - | ₹282.74 | - | - | - |
| Net Profit TTM (₹ Cr) | ₹-24.37 | - | ₹15.30 | - | - | - |
| PE TTM | -2.60 | 13.00 | 26.10 | - | 7.70 | 35.90 |
| 1 Year Return | 657 | -23.44 | -18.29 | 19.25 | -47.67 | 115.89 |
| ROCE | -5.63 | - | - | - | - | - |
Medicamen Organics Ltd.
₹ 24.00
+1.05%
Amrutanjan Health Care Ltd.
₹ 601.00
-0.07%
Senores Pharmaceuticals Ltd.
₹ 763.00
-1.49%
Innova Captab Ltd.
₹ 665.50
-1.16%
Valiant Laboratories Ltd.
₹ 57.11
-3.37%
Sigachi Industries Ltd.
₹ 20.20
+0.15%
Windlas Biotech Ltd.
₹ 754.10
-1.46%
Vineet Laboratories Ltd.
₹ 29.99
-1.93%
Solara Active Pharma Sciences Ltd.
₹ 459.50
-0.77%
Zim Laboratories Ltd.
₹ 69.02
-2.02%
Medico Remedies Ltd.
₹ 44.60
-0.91%
Dishman Carbogen Amcis Ltd.
₹ 177.15
-4.19%
Lasa Supergenerics Ltd.
₹ 7.98
+1.66%
Advanced Enzyme Technologies Ltd.
₹ 306.00
+1.86%
Bajaj Healthcare Ltd.
₹ 330.50
-0.39%
Ortin Global Ltd.
₹ 17.19
+4.95%
Brooks Laboratories Ltd.
₹ 66.60
-2.06%
RPG Life Sciences Ltd.
₹ 1867.80
-2.17%
Bafna Pharmaceuticals Ltd.
₹ 104.03
-1.21%
Alpa Laboratories Ltd.
₹ 65.54
-0.05%
Sun Pharma Advanced Research Company Ltd.
₹ 127.53
-0.70%
SMS Pharmaceuticals Ltd.
₹ 382.80
-1.69%
Nectar Lifesciences Ltd.
₹ 12.19
+0.08%
Mangalam Drugs and Organics Ltd.
₹ 28.85
-3.74%
By signing up I certify terms, conditions & privacy policy